David M. Hilbert

Affiliations: 
1983-1987 Immunology Graduate Group University of Pennsylvania Perelman School of Medicine 
 1987-1995 Laboratory of Genetics NIH, NCI 
 1995-2005 Research and Development Human Genome Sciences 
 2010- Founder, VP for research Cellective Therapeutics 
Google:
"David Hilbert"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

LaFleur DW, Abramyan D, Kanakaraj P, et al. (2013) Monoclonal antibody therapeutics with up to five specificities: functional enhancement through fusion of target-specific peptides. Mabs. 5: 208-18
Kanakaraj P, Puffer BA, Yao XT, et al. (2012) Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis. Mabs. 4: 600-13
Stohl W, Hilbert DM. (2012) The discovery and development of belimumab: the anti-BLyS-lupus connection. Nature Biotechnology. 30: 69-77
Woodland RT, Fox CJ, Schmidt MR, et al. (2008) Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood. 111: 750-60
Cambridge G, Stohl W, Leandro MJ, et al. (2006) Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis and Rheumatism. 54: 723-32
Collins CE, Gavin AL, Migone TS, et al. (2006) B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels. Arthritis Research & Therapy. 8: R6
Fleming TJ, Sachdeva M, Delic M, et al. (2005) Discovery of high-affinity peptide binders to BLyS by phage display. Journal of Molecular Recognition : Jmr. 18: 94-102
Stohl W, Metyas S, Tan SM, et al. (2003) B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis and Rheumatism. 48: 3475-86
Baker KP, Edwards BM, Main SH, et al. (2003) Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis and Rheumatism. 48: 3253-65
Stewart DM, McAvoy MJ, Hilbert DM, et al. (2003) B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro. Clinical Immunology (Orlando, Fla.). 109: 137-43
See more...